A Phase 1, Open-Label, Randomized, Single Dose, Parallel Group Study to Assess the Pharmacokinetics and Pharmacodynamics of PF-04950615 Following Subcutaneous and Intravenous Doses in Adult Subjects With Hypercholesterolemia.
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2012
At a glance
- Drugs Bococizumab (Primary) ; Bococizumab (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- 07 Nov 2012 Pooled analysis presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 29 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Actual patients number is 49 as reported by ClinicalTrials.gov.